ARTICLE | Financial News

Microbiome company Enterome raises €32M

January 5, 2018 9:17 PM UTC

Enterome Bioscience S.A. (Paris, France) raised €32 million ($38 million) on Jan. 4 in a series D round. New investors Principia SGR and Bristol-Myers Squibb Co. (NYSE:BMY) and all existing investors -- Seventure, which invested via several funds including its Health for Life Capital; Lundbeckfonden Ventures; Omens Capital; and the Nestlé Health Science subsidiary of Nestlé S.A. (SIX:NESN) -- participated in the round.

In conjunction with the offering, the microbiome company also secured a €40 million ($47.5 million) loan facility from the European Investment Bank...